OKLO
Earnings day, with a side of nuclear drama
Oklo is heading into its Q1 earnings call after the closing bell on May 12th, and the setup is pretty classic pre-earnings theater: analysts expect a bigger loss, but also more revenue than a year ago. In other words, the company is still in the expensive part of the rocket ship ride.
Why investors are leaning in
The market doesn’t just care about the numbers on the income statement here. Oklo is one of those names where every regulatory breadcrumb matters, because the whole thesis depends on turning futuristic nuclear ambition into something that actually gets built.
That’s why the fresh news from May 6 still matters: the U.S. Nuclear Regulatory Commission approved the Principal Design Criteria topical report for Oklo’s Aurora powerhouse, which is under construction in Idaho. Translation: one more bureaucratic hurdle got cleared, and that’s the kind of thing investors in this space treat like a small victory parade.
Analysts are doing the usual pre-game dance
Ahead of the call, a handful of analysts refreshed their takes:
- JPMorgan started coverage at Neutral with an $83 target
- Tigress Financial came in at Hold with a $130 target
- HSBC kicked off at Buy with a $96 target
- UBS and Goldman both stayed Neutral but cut their targets
So yes, the Street is still split between “this could be huge” and “this is still very much a moonshot.”
Big picture: Oklo’s stock isn’t just trading on earnings. It’s trading on whether the company can keep turning regulatory green lights into a real business, and that’s a much harder trick than writing a PowerPoint about clean energy.